Health Canada drug identification number

DIN 02530740 — LIVTENCITY 200 MG

LIVTENCITY is a tablet of Maribavir marketed by TAKEDA CANADA INC. The full Maribavir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02530740
Brand name
LIVTENCITY
Active ingredient
Maribavir
Strength
200 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
TAKEDA CANADA INC
Health Canada status
MARKETED
Drug class
Antiviral agent (CMV UL97 kinase inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.